{"id":958136,"date":"2026-05-05T08:56:52","date_gmt":"2026-05-05T12:56:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/"},"modified":"2026-05-05T08:56:52","modified_gmt":"2026-05-05T12:56:52","slug":"clene-to-present-at-upcoming-may-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/","title":{"rendered":"Clene to Present at Upcoming May Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SALT LAKE CITY, May  05, 2026  (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the following investor conferences in May.<\/p>\n<p>\n        <strong><br \/>\n          <u>Emerging Growth Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Date:<\/strong> May 6, 2026<br \/><strong>Time of Presentation: <\/strong>3:25 p.m. ET<br \/><strong>Format:<\/strong> Virtual Presentation<br \/><strong>Presentation Link:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bRAK-AnnfZw73OMmLlIwUWXbY1n40LbAD_zBTphEpmdrolCWJWT7yDagjf_ynLLjYbEe5S5dYzSHJyQbPhAdOLa1o-ZEahzydXTTx_UWou1QKZLtO3QP9svlY3DHN2DIc2n1wIF1gxO8uCX0yYpXFAPP3gnalq73LZsiqWVnTDpIq6d1EMuVXANS8OuNyWN03jwKlNzEQj80GlbNLdKV2OeHnhXOkaJ3ZpxFoVRwQgcbysBh5I_4aP0X4AXHIRou\" rel=\"nofollow\" target=\"_blank\">https:\/\/goto.webcasts.com\/starthere.jsp?ei=1755070&amp;tp_key=280dc3ffe3&amp;sti=clnn<\/a><\/p>\n<p>\n        <strong><br \/>\n          <u>D. Boral Capital Global Conference <\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Date:<\/strong> May 7, 2026<br \/><strong>Location: <\/strong>The Plaza Hotel, New York, New York<br \/><strong>Format:<\/strong> 1&#215;1 meetings<\/p>\n<p>\n        <strong>About Clene<\/strong><br \/>\n        <br \/>Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis. CNM-Au8<sup>\u00ae<\/sup>\u00a0is an investigational first-in-class therapy that improves central nervous system cells\u2019 survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8<sup>\u00ae<\/sup>\u00a0is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&amp;D and manufacturing operations in Maryland. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KpHQwfYbVCWfov-aPJ1lBejAlTE7gl319rTBL6ApsCOYgsCHTMMX0lUsWzjjKfbSW1dQWp1bmDOoH-Qfpd1X6uhFMiDyl-Xq_FCA_kRTWLGoQ00qwTDbUdk3aaff42QbzHkeGA9mMOSN3il1SBuZEXWPL8RZ5JCncLoN6Ys0uZTYZcMByFzpbgh9v1tibSuc3hrpsbT38zzIE56ElWAJ5wc_3VAZq2Vk7skpS9uLCpB846Oddxgpu1OCIWllOnE-FXxE-l0jG-JTL04sk5mZ_ISUYsa6aNqde1YHgug9NNJ6Hl4zxURMf1hESjsRig7PWT-j78tB8v-es7MuihXKX4RclIY8NlgF4wM0ZTOYFIXesb7ljLkM388a6apyWGudpmZZStLqj6Kg595bvNi2UX5z15seO2Pjz9IXJjDm7ypeHInpwCUJi9uLlhMWF0I6OAN5OJnPFSLnzWNq4apQqB8KdMwl77kVbQdOstQJak45I5_ZmvWEDZw6P7pxGH_dS7Zb4rDz7SyiCrF_ew-H1w2l9ruR8nkaevPGOQsiu2o1rOUoxlddio2XixHjWoh8k-mFmKnqYp6xf8NPTNtJMJTXGCktFJ4CjXzaOWHHRupwb0FdQfE33t4ULo2xAE3WE8oEKz10QmLMe_C6Nvh1L8HcSxGxLBP05hOmeTLNx0C82PxF3HlPUBmz6N5fSzel_j18JEq63z8CPK1PN0Si5IH7sKIl3aTvLcpe2wxasyY1UkD42cvbvAw43gpGXtnryLUu0qxqmBPECWigzN_Bhf0uzL47GAZCYIf6vs8i9pwumanqxy44QWYJUYl0VTJhcVxqVEwKUr7H_-n_-_qdxhHW7MsJKs1zq0PSXoQao_p1foS7Doyp4dgfcUdHkO84V-EevTDBj4FsdRizXSArwv_jN9CZckyY2nbbDyJmiIODJShRiLl596hPTrOSRsnsv01HnNaMbscrxqj_X1vYttWzKRU7NXebNqO-adPGRgOFeGTmA0nJq7AEj-Znm4qf27fEKaJWy-tlSzMt9DWgkp-OH-nVvZyPoknj9YZTtKnlbqynwUDAC8rb4GEUSwXs3Gcm1gwThlu9hkD1ZvrlPAIyRIgm8sEfYKmmHAgGDcO8LxaPbFTzBYiZdVYUH0RM_pYHxj_rr4Zr7vcVfSu6U03ROfE9t3wkb2Y69V3pT0s-PQfdOdinXQhNjXexBVrtGKShTnPlopwZAuXO4lGeTz07h_4TMjMAZPNXRBffTVJSFgReFgtjxcJ07Bz70i9zvnJyXhO8wSCpvZGEGfbiZrYHClXtvSGx9eJ4HXJW2y3X85-lNxKITIsIbj_V85T-8sqHLB-TOjr-wjRLbn89_Eb6cvXgvnsM0esd5Dfz2JRRHSDdkhJYHtkr4DvlMUsv19baM-q-jT40PV07YZJ1CASG-w5pRCoGrsxnPVmT87ZlblIYG4UQYdfV8qkFBUkBdSmusMw6tm4A5ef8MMmilA==\" rel=\"nofollow\" target=\"_blank\">www.clene.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GpXOeiKZDpcS7l9VYTjJ-Sg5TN00O5uibFS3yMYXeD2j-X71xP56UQQPVYaEXzVHUfpo7ZwtBrghAJwrnC6xsOQEtgpoDRrZ7fyQwGyNs4cLOwjsRCfN8QX8bQajXbPov5OOgDhX9DefZZwMfpSGeg65LjMqskNl_yhSQeu4JvbahfQbux9Ix1_ABYdfn2Z30IqQiNOGEu85aQd8eqmzPMKjERdw8gOiAc3hgHH7d7aQOgmN8X9XRZHAEAcModWxFAQbmD05QNYgUP33LA73QaoNmvmFzKrLgS-4SyzI0JiTisKY19sjgCLNqcXmFGioVgtmTzswwD7Ag-zXuKp3pan_3AJjrWeWJj2h5elh0tHglUMTlmy2-jHP9uXUwLpY5uXbQHVqnjA_vjZ1ESZGIgIRTgt6O5z6WCTyEzVnIrhTp3fkM6JjRTdTgBmA8DQTa4b948h6eSfrOpqh6oPcnhJpCdbu3irV4AZp4PXOqJF9ypye47vBifDVEcYC7eZ8PCCSAEW7GLSAqO7P4f0xY1lXAXGRamiTDXFFBlHZlU1pqmxH2RgPNMBg6GwHzbtRz4AJF8cwhvBY3cRDnYB_uuC9etxUiFEdgDyIkWyAbWXT6BE0V_bequzNb91-dS35Hrl0Ym-MMlT9K1qtvsAKaDCEL_pVFuiSuX-jHxHy7rDxEZV_bmqpYTpSspTYfV1UBjQa4epZXCKGdtJZke7HbKXbt8TP18xL1cslLCDLsTj1sAIiY_7xY4MYXAxAxjPOGTEP8Z6hWhi9cVUOqY6iU0PSIRhlyqz4PLNHh0kZ5UmdYGAFGQSwYqhiOhDzcICj6YhfuwcsIqHaqAs3sQBwUA1CmaZCbIm_hpPhSVDJBIpsRYahfjBi9-LBCEGptjTxYPyOMSmY96CmGdI9K7nXoFuhxNOtTX9KWvIFcEeHI2qMqOZ6W1L_QiVCeWFsoo9izVr-o5pGglRe9azH3OYPrkXUOa6R0Din9SiuD26SOcdY2Gc5CB2lxtgTIQVwP64fpZT_Qo3gSTne9IRbIdAJdVmm0EbHir1WNP4AxdSbeZQMyQGM2Va-sFIokeFKZZNyTsHix66b7h9AeiXMRS4zSAcibCafW8Nd2s_sSxRZJVblloNgyUzpTNXnFfFlIQv3PdMStC4m8KYkbwrFtZv5aPXPNR_oHoEQAe5tEmj9yJwoA7a3y1JoE7aCDU0lOZz4OQZhzXF9TucbtX_wUKVqHIX35tokHZ8QByDMJh_yvBn_Qw5cQK_ZeuZafg5tbgQoCSBpRm-j3cIJYtIlJ9qokUbIlE0zeaIo8ZLYph0rutDtUmepM0_vMuhvKl3WQ4PQv5TBMzhCwpKbI2ZRLs-Ptq6KUd9Aua3d1LhfHbwPbj69I_F_U91JMpNkQEEnAAbyKVs7CknDdNVJ1UcxmOB08dcDPtlgKIH-hqHNIyOtk32fQ3-VU7EDI65rzbAeyak1eQXc8pknXJm5BfbLVGfR5i8xZU12oYSpaiSJwNWG5nMZp7QszrWxyJMQLUDFXURFz-Z0S-uTEwuVYWlw3UTX2qD0DWkVT6pYqkmpNKu1ma4=\" rel=\"nofollow\" target=\"_blank\">X (formerly Twitter)<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FeOgbaYinN_niRhB9XXkrZEQKjxhaEXxAMQiOunhOeT7urwfquWSfMRuXlvKB8XgP18ZedDsp5qTGpiwwQ_niyCRWV-WA9CB3RqhHlkuoTyCSnp5ojLR56q68SFeySgNJ-EQZonxKMWO7urA7lcGEnDI6qTOkQh1y4gI00Mu5XZto_2I-j2844L_7aJlUnwfv4rAlRMd_6ZKa3ZDbY6FEvtXcBJEJ-J4v_-pjdTmQ-lrEIEnEVPx6YrSq_HfDAkAfaEjqQW9-f2kxGZRKB19JmaEs2TdhVpKrysnL56Jla-hYdQZp3IH_pWdU9SY73tbwp4h-TQ530EtKIgyygBc078MJwcITLN8EGR5ESdwsnyDmTHHL-UYCMXWhv7QActWHzOI2_PuxiL4Peg1_IEac3RdRyY4prAXo1muqxmIl6X_bN8rjlZfbA0vC7lFDrliy_cyVJTUiX9UD5CdqN6JUA2zir7FvG1TcEiTv2IvSXaZ14X0xYSwCUSMAuWd6Rto6BW61U55HOjWZSj1XBOmCr0NCzMnWPe0Pj8EFGX5kPf-BE5_1Bp63WGdOz5lEzfXbG5oFSHHRwNmPiIDjeZsGotgftTkDJNp1ySWKuVITGLBp0FM2zXl355wb-Bq03QnXhKhkHq-zbEd7eYKfATS4U2FbKatNTOUsvchmOoAiiqNk86Pa2iLkrIJx9T2BWsg0iLBtXfjD9FsT1yYMyMk-vIkLk9q1MH_Q40K9L3Fesoe0r17L1Q_0dlV73LhF-NTJee0mfC9uhxtVmIHSQ8i9URTy4r6VY--6Rj3oLcmZ7lnTzLvGIoDv2_fivwOmGSUMoxd9Fq8ZWn3AIYhBYE3m0PcLHytzM3i6cbrouIP2qwnDHlwiqP5nzxyHTxPtCVNnJHuUdlr8Kd3HW2Nu3Hn_HCchjHavjGV7FdLM8rYKBoudg7gpNDWgmADw-OdKuLojCYmOVpc3PuJJm6KzSrARK-XCSHjLXse7Dc-vlDj85glwRkUT3zQqxdfGsqyVd36ZNt1zaIXb2MQhB_Ch1snr3nkfS-cu1-mQ8zW8fetgdKGh13RDECsXfRE_XhPVDde6vVU-5cNFfkJlaQXYxuY_EmFp0FtuiNm4qZMhBpEVUaaQs2-wK4mvyypXKf0S9SGTBjmkODdwuxuWpYaOjYc1C7LQvLb4DJvZmiuYI8wDUyJ8fDYmLto_OOd4i3YU8IRCiZAe-jyZNTh1DO0z5zbUPXQaHH6F1xFqZTlcNsvBhsAv8B_fBwQq91Xjur4_e_UHvb2ZyGpTr0FYTvN7jx9BLa8kKRbD0zxZOm-hA837ZNfzeOA5tj_XO-TIgVDdg2rrLwD2Vov88k2gCZKYMsW7QJzGEj0nPaCSXxLj96l01zaAtO12KXYqaRfqjNh5I1cWIDgJR6l8rRNao9NmlYdYGEGOm7cB_4euQLsTOtmA8XHonRNCHxFK1K29sC05unQg4EvJwhpFzlQ0cb6f1eQzfX2LUWej0Vp909Fr8r5hpjJsZZZDKWo9A6sfm2khYCNA2faIXD9SQy_ekN_NlYbzgmvapEmXBZJT-Ea_2nH4v2GIpQ20jI9nstTNdbd1A4hHtQHMbV6Da5DH6jxD8j6Ow==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong>: Kevin Gardner, LifeSci Advisors;\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZTWnFa7n7Ij_ZMb9QBVnmkCNRDX_Sn8f3NYH7bbz_WXtUwIEMj_vji5FjxWYEtQ7xqTPRQBRjDxXgAO5VsXPcHWtm9VOaTWbfftNC590yROkBr8tQhCJ2UWQp0UL66OwrnCdjKeakpL16jdjuBpAu4rEYpu3C9Tj_Su3d4eTncBD1U5XHk3Y-8LZ3qvBdU8b9jDQufjeaJ00KOQ2XHeVKYqKC6o8M0Z1Zj7c6XpZX4Kx-cM7Ds2VuCh13-77jVIxW6LvpQuOxfvdU3WlEJvYTsbbffIAN0hxRE6Sos6CmuZ9esDaYWk943szvP_ehFCN\" rel=\"nofollow\" target=\"_blank\">kgardner@lifesciadvisors.com<\/a>; (617) 283-2856<\/p>\n<p>\n        <strong>Media Contact: <\/strong>Caroline Wagner, Forbes Tate Partners;\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AuHvvgQ58ROI0hNTLd19978cvpS4Oke7P8HSEZ8Zz8szcAbhRxfvFynwXU-JZ6xyi1kku-eUV6Bzo9nt74VqBBP0MYR66f9Hy4gPzIxMxv0=\" rel=\"nofollow\" target=\"_blank\">CWagner@forbes-tate.com<\/a>;\u00a0(267) 294-6563\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTA2MGRhZTUtNGI2OC00NGE4LWE4Y2QtZjg0NWJlNTNhODkxLTEyNTc5OTktMjAyNi0wNS0wNS1lbg==\/tiny\/Clene-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the following investor conferences in May. Emerging Growth Conference Date: May 6, 2026Time of Presentation: 3:25 p.m. ETFormat: Virtual PresentationPresentation Link:https:\/\/goto.webcasts.com\/starthere.jsp?ei=1755070&amp;tp_key=280dc3ffe3&amp;sti=clnn D. Boral Capital Global Conference Date: May 7, 2026Location: The Plaza Hotel, New York, New YorkFormat: 1&#215;1 meetings About Clene Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clene to Present at Upcoming May Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-958136","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clene to Present at Upcoming May Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clene to Present at Upcoming May Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the following investor conferences in May. Emerging Growth Conference Date: May 6, 2026Time of Presentation: 3:25 p.m. ETFormat: Virtual PresentationPresentation Link:https:\/\/goto.webcasts.com\/starthere.jsp?ei=1755070&amp;tp_key=280dc3ffe3&amp;sti=clnn D. Boral Capital Global Conference Date: May 7, 2026Location: The Plaza Hotel, New York, New YorkFormat: 1&#215;1 meetings About Clene Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused &hellip; Continue reading &quot;Clene to Present at Upcoming May Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-05T12:56:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clene to Present at Upcoming May Conferences\",\"datePublished\":\"2026-05-05T12:56:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/\"},\"wordCount\":259,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/\",\"name\":\"Clene to Present at Upcoming May Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=\",\"datePublished\":\"2026-05-05T12:56:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-may-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clene to Present at Upcoming May Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clene to Present at Upcoming May Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Clene to Present at Upcoming May Conferences - Market Newsdesk","og_description":"SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the following investor conferences in May. Emerging Growth Conference Date: May 6, 2026Time of Presentation: 3:25 p.m. ETFormat: Virtual PresentationPresentation Link:https:\/\/goto.webcasts.com\/starthere.jsp?ei=1755070&amp;tp_key=280dc3ffe3&amp;sti=clnn D. Boral Capital Global Conference Date: May 7, 2026Location: The Plaza Hotel, New York, New YorkFormat: 1&#215;1 meetings About Clene Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused &hellip; Continue reading \"Clene to Present at Upcoming May Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-05T12:56:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clene to Present at Upcoming May Conferences","datePublished":"2026-05-05T12:56:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/"},"wordCount":259,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/","name":"Clene to Present at Upcoming May Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=","datePublished":"2026-05-05T12:56:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcwMyM3NTgyMzc2IzIyNDY0NDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-may-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clene to Present at Upcoming May Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=958136"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958136\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=958136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=958136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=958136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}